Introduced
S. 3751
Introduced in Senate · February 20, 2026January 29, 2026
Mr. Bennet (for himself and Mr. Lankford) introduced the following bill; which was read twice and referred to the Committee on Finance
A BILL
To require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Prescription Drug Supply Chain Pricing Transparency Act”.